ADC Therapeutics SA reports material agreement in SEC 8-K

ADC Therapeutics SA filed an 8-K covering a material definitive agreement, results of operations or financial condition, and an unregistered sale of equity securities. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.